|
業務類別
|
Drug Manufacturers - Specialty & Generic |
|
業務概覽
|
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild tomoderate pain. |
| 公司地址
| 100 South Saunders Road, Suite 300, Lake Forest, IL, USA, 60045 |
| 電話號碼
| +1 224 419-7106 |
| 傳真號碼
| +1 510 744-8001 |
| 公司網頁
| https://www.assertiotx.com |
| 員工數量
| 58 |
| Mr. Sam Schlessinger |
Executive Vice President and General Counsel |
-- |
08/04/2025 |
| Mr. Mark L. Reisenauer |
Director and Chief Executive Officer |
-- |
30/10/2025 |
| Ms. Mary E. Pietryga |
Executive Vice President and Chief Commercial Officer |
-- |
08/04/2025 |
| Mr. Paul Schwichtenberg |
President and Chief Operating Officer |
美元 430.05K |
10/11/2025 |
| Mr. Ajay Patel |
Executive Vice President, Chief Financial Officer and Chief Accounting Officer |
美元 445.39K |
08/04/2025 |
|
|
| Mr. William T. Mckee |
Independent Director |
08/04/2025 |
| Ms. Heather L. Mason |
Chairman of the Board |
08/04/2025 |
| Mr. Mark L. Reisenauer |
Director and Chief Executive Officer |
30/10/2025 |
| Mr. Brendan P. O’Grady |
Director |
30/10/2025 |
| Mr. David Matthew Stark |
Independent Director |
08/04/2025 |
| Mr. Sravan K. Emany |
Independent Director |
08/04/2025 |
| Mr. Sigurd C. Kirk |
Independent Director |
08/04/2025 |
|
|
|
|
